Modified Olfactory Training for Patients With Olfactory Disfunction:A Randomized Clinical Trial
Modified olfactory training device
Olfaction Disorders+3
+ Nervous System Diseases
+ Neurologic Manifestations
Treatment Study
Summary
Study start date: July 1, 2023
Actual date on which the first participant was enrolled.This study focuses on improving a therapy known as olfactory training, which helps people with a reduced sense of smell. The standard method involves patients repeatedly sniffing various odors to enhance their olfactory abilities. However, this approach often faces issues such as inconsistent methods and difficulties for patients to stick with the program. To address these challenges, a new device has been developed that uses pressure from breathing out, offers a two-way airflow, and includes features like voice prompts and automatic counting. This study is significant because it aims to provide a more effective and user-friendly method to help those struggling with smell disorders, potentially leading to better patient outcomes and adherence. The study plans to involve 72 participants, who will be divided into two groups. One group will use the traditional olfactory training methods, while the other will try out the new device. Participants will engage in regular sessions using their assigned method, and researchers will compare the results between the two groups to evaluate the effectiveness of the new device. The study does not specify risks but focuses on improving how well patients can follow the olfactory training and the potential improvements in their sense of smell.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.72 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 80 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location